Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIO|REDUCE: Cardiac REsynchronization Therapy With Two Ventricular Leads and Right Atrial Floating Diagnostic Dipole Installed in the Right ventricUlar Lead in Patients With CRT-D indiCation and no Sinus nodE Dysfunction

NCT03839121 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.

NCT NCT03839121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03839121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIO|REDUCE: Cardiac REsynchronization Therapy With Two Ventricular Leads and Right Atrial Floating Diagnostic Dipole Installed in the Right ventricUlar Lead in Patients With CRT-D indiCation and no Sinus nodE Dysfunction
Lead sponsor
Biotronik SE & Co. KG
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
June 8, 2023
Enrollment
113 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac resynchronization therapy, heart failure